An Oklahoma City hip and knee surgeon who offers platelet and bone marrow injections as non-surgical options alongside a joint replacement practice.
This listing covers the practice of Dr Kyle McGivern, an orthopaedic surgeon specialising in hip and knee problems, who works within Direct Orthopedic Care in Oklahoma City. The site gives two offices: Oklahoma City North at 3705 NW 63rd Street, Suite 201, and Oklahoma City South at 3130 SW 89th Street, Suite 200, with appointments bookable online. The bulk of the practice is surgical - total, partial and revision hip and knee replacement, anterior hip replacement, hip resurfacing, robotic-assisted knee replacement, arthroscopy, anterior cruciate ligament reconstruction and fracture surgery - with injection treatments offered as a non-surgical alternative for suitable patients.
Two injection treatments are named: platelet rich plasma (PRP), which the site describes as blood processed to concentrate platelets and white cells, and bone marrow aspiration concentrate (BMAC), described as regenerative cells taken from the patient's own bone marrow. Both are autologous, meaning the material comes from the patient's own body. The site groups these under the heading orthobiologics, which it defines as natural substances - cells, tissue, blood components and growth factors - used to treat orthopaedic injuries. It also discusses cartilage transplantation, where tissue is taken from elsewhere in the patient's own body or from a donor; that is a surgical procedure rather than an injection.
The conditions named for these treatments are articular cartilage injuries, early osteoarthritis, and ligament and tendon injuries. Notably, the orthobiologics page makes no claims about success rates or outcomes and cites no published evidence, which is a more restrained approach than many clinics take but also leaves a patient without much to go on. It does not say how many injections a course involves, how suitability is assessed, or what the alternative would be if the injection does not help - all reasonable things to ask at a consultation.
The site gives Dr McGivern's training - a zoology and biomedical science degree from the University of Oklahoma, medical school at the Virginia College of Osteopathic Medicine, and an internship and orthopaedic surgery residency at St Anthony Hospital in Oklahoma City - and lists membership of the American Academy of Orthopaedic Surgeons, the American Association of Hip and Knee Surgeons, the American Osteopathic Association and the American Osteopathic Academy of Orthopedics. No other clinician is named. Nothing is published about the cost of the injections or whether insurance covers them, which is the main practical gap for a patient.
The conditions named for orthobiologic treatment are cartilage, ligament and tendon problems and arthritis in its earlier stages.
The site states that its cell treatment uses bone marrow aspiration concentrate taken from the patient's own bone marrow, and that platelet rich plasma is produced by processing the patient's own blood to concentrate platelets and white cells.
One surgeon is named on the site.
The practice runs from two Oklahoma City offices, one in the north of the city on NW 63rd Street and one in the south on SW 89th Street, operating within the Direct Orthopedic Care group. These are described as consulting and outpatient offices; joint replacement and arthroscopic surgery would take place in a hospital or surgical centre, which the site does not name. Injection treatments are presented as office procedures, and bone marrow would be taken and processed during the visit, though the site gives no detail of the equipment or processing used, and does not mention imaging guidance. No accreditation, founding year or languages are stated, and appointments are booked through an online system rather than a published telephone number on the home page.
The site publishes no prices for platelet rich plasma or bone marrow concentrate injections and makes no statement about insurance cover for them. Since the practice bills insurance for joint replacement and fracture surgery, a prospective patient should ask specifically whether the injection pathway is insured or self-funded, how many injections would be expected and what the total cost would be.
Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.